Skip to content

Synergistic Anticancer Effects of Gemcitabine-Functionalized Au Nanoparticles in Combination with Radiotherapy and Ultrasound Irritation in MCF-7 Cells

Jul 2026 · Journal of cluster science · Vol 37 · 0 citations · 67 references

TL;DR

Gem-PEG-Au can be an effective agent for the combined treatment of radiotherapy and ultrasound-based treatments and showed considerable radiosensitizing and sonosensitizing capabilities, leading to enhanced therapeutic performance under radiotherapy and ultrasound exposure and concurrently limiting potential adverse outcomes.

View source

Similar papers

Open access Sep 2026

Boosting Antitumor Activity: CuO Nanoparticles Enhance Pemetrexed Efficacy and Increase hsa-miR-548c-3p Expression in Human Lung Cancer

Background and objective — Lung cancer, particularly non-small cell lung cancer (NSCLC), is a leading cause of cancer-related death. Pemetrexed (PEM) is recognized as an effective chemotherapy drug. However, its efficacy is often compromised by resistance and side effects. Copper oxide nanoparticles (CuO NPs) are promi...

Sepideh Mokabberi, Nahid Babaei, H. Ghaleh et al. · 0 citations
Sep 2026

Tumor microenvironment responsive CuV/DTPA@Catalase/5-fluorouracil nanodrug for reactive oxygen species modulation and breast cancer imaging.

A multifunctional nanodrug system, CuV/DTPA@Catalase/99mTc-5FU, engineered for enhanced anticancer efficacy and imaging that can overcome limitations of conventional chemotherapy by regulating the NF-κB pathway and enabling precise drug delivery is presented.

Iqra Iqbal, Ummama Saeed, B. Fatima et al. · 0 citations
Oct 2026

B-066 Development and Characterization of mPEG-Chitosan Nanoparticles for the Co-delivery of Curcumin and KRAS-targeting siRNA in Lung Cancer Models

Lung cancer represents one of the most lethal malignancies worldwide, exhibiting both high incidence and mortality rates. It remains the primary cause of cancer-related deaths among men and women. Several factors contribute to its lethality including late diagnosis and the limited effectiveness of current treatme...

Lujain Alkhalaileh, M. Bayachou · 0 citations
Open access Oct 2026

Combination of Organoselenium-Loaded Nanoparticles and Conventional Chemotherapeutics Synergistically Enhances Antitumor Efficacy and Modulates Multidrug Resistance: An In Vitro Study

Background/Objectives: Cancer causes high premature death worldwide, with 35 million new cases expected by 2050. Multidrug resistance (MDR), driven by genetic and epigenetic changes, hampers chemotherapy. In this study, polymeric nanoparticles (NPs) were formulated with an organoselenium nucleoside analogue (AFAT-Se) t...

Bruna Fracari Do Nascimento, Bianca Costa Maia-do-Amaral, Taís Baldissera Pieta et al. · 0 citations
Open access Sep 2026

EGFR-Targeted Nanoparticle Delivery of Osimertinib for Triple-Negative and Metastatic Breast Cancer Therapy

Background/objective: Osimertinib, an EGFR-targeted agent approved for metastatic NSCLC, shows promise for triple-negative breast cancer due to EGFR overexpression in aggressive tumors. However, oral administration limits tumor delivery and causes systemic side effects. This study aimed to develop chitosan-coated PLGA...

Iman M. Alfagih, Maryam Alfagih, Alanood S. Almurshedi et al. · 0 citations
Open access Sep 2026

ZIF-8 Nanocarrier-Based Co-Delivery of Curcumin and 5-Fluorouracil for Synergistic Antitumor Activity in Hepatocellular Carcinoma

Background Hepatocellular carcinoma (HCC) is a highly prevalent malignancy worldwide, posing a severe threat to human health. Although conventional chemotherapy remains a primary treatment modality, its clinical efficacy is limited by poor targeting, drug resistance, and systemic toxicity. To address these challenges,...

Long Zhang, Wei-Jie Zhu, Lei He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.